(Q37960805)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116469%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Oxidative stress in phenylketonuria: future directions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116469%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116469%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Maria João Martins

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116469%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Júlio César Rocha

series ordinal

1

1 reference

26 August 2017

Maria João Martins

series ordinal

2

1 reference

26 August 2017

publication date

25 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116469%20AND%20SRC:MED&resulttype=core&format=json

Journal of Inherited Metabolic Disease

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116469%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116469%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116469%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

381-398

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22116469%20AND%20SRC:MED&resulttype=core&format=json

Metabolic syndrome and oxidative stress

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Plasma phenylalanine is associated with decreased serum ubiquinone-10 concentrations in phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

A longitudinal study of antioxidant status in phenylketonuric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Oxygen, reactive oxygen species and tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Metabolic syndrome and periodontitis: is oxidative stress a common link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

The paraoxonases: role in human diseases and methodological difficulties in measurement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Inhibition of brain and liver 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate-5-pyrophosphate decarboxylase in experimental hyperphenylalaninemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Is there a relationship between plasma phenylalanine and cholesterol in phenylketonuric patients under dietary treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Ubiquinone-10 content in lymphocytes of phenylketonuric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Position of the American Dietetic Association: vegetarian diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Dietary phenolics: chemistry, bioavailability and effects on health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Paraoxonase 1 interactions with HDL, antioxidants and macrophages regulate atherogenesis - a protective role for HDL phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Suboptimal outcomes in patients with PKU treated early with diet alone: Revisiting the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Antioxidant vitamins and their use in preventing cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Nutritional issues in treating phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Multiple actions of high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Sites of action of carnitine and its derivatives on the cardiovascular system: interactions with membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Increased oxidative stress in obesity and its impact on metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Paraoxonase, a cardioprotective enzyme: continuing issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Antioxidant and antiradical activities of L-carnitine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Influence of habitual diet on antioxidant status: a study in a population of vegetarians and omnivores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Alterations in lipoprotein defense against oxidative stress in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Coenzyme Q10 in phenylketonuria and mevalonic aciduria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Blood mononuclear cell coenzyme Q10 concentration and mitochondrial respiratory chain succinate cytochrome‐c reductase activity in phenylketonuric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Oxidized LDL and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

A novel component of the metabolic syndrome: the oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Health effects of vegetarian and vegan diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Assessment of mitochondrial respiratory chain function in hyperphenylalaninaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

European research on the functional effects of dietary antioxidants - EUROFEDA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Free use of fruits and vegetables in phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Cellular response to oxidative stress: signaling for suicide and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

The evolution of free radicals and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Zinc: role in immunity, oxidative stress and chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Antioxidant effect of zinc in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

The three-gene paraoxonase family: physiologic roles, actions and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Oxidative stress in phenylketonuria: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Atherogenic dyslipidemia and oxidative stress: a new look.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Large neutral amino acids supplementation in phenylketonuric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Effect of diet on plasma total antioxidant status in phenylketonuric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

The effect of diet on total antioxidant status, ceruloplasmin, transferrin and ferritin serum levels in phenylketonuric children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

A review of the interaction among dietary antioxidants and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Oxidative stress in patients with phenylketonuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Investigation of oxidative stress parameters in treated phenylketonuric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

L-carnitine blood levels and oxidative stress in treated phenylketonuric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Free radicals, metals and antioxidants in oxidative stress-induced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Free radicals and antioxidants in normal physiological functions and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Future treatment strategies in phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

How practical are recommendations for dietary control in phenylketonuria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Selenium, glutathione peroxidase (GSH-Px) and lipid peroxidation products before and after selenium supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Diet and Cancer – An Overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Diet and cancer--an overview (second of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

The oxidative modification hypothesis of atherosclerosis: does it hold for humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Antioxidants in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9417-2

Antioxidant status in hyperphenylalaninemia

21 January 2018

1 reference

12 December 2020

Serum paraoxonase/arylesterase activities in phenylketonuric patients on diet

1 reference

12 December 2020

Moderate zinc deficiency in rats enhances lipoprotein oxidation in vitro

1 reference

12 December 2020

Lipophilic antioxidants in patients with phenylketonuria

1 reference

12 December 2020

Decreased serum ubiquinone-10 concentrations in phenylketonuria

1 reference

12 December 2020

Effects of milk and milk components on calcium, magnesium, and trace element absorption during infancy

1 reference

12 December 2020

Blood phenylalanine control in adolescents with phenylketonuria.

1 reference

12 December 2020

Effects of a low selenium state in patients with phenylketonuria

1 reference

12 December 2020

1 reference

12 December 2020

Effect of phenylalanine derivatives on the main regulatory enzymes of hepatic cholesterogenesis

1 reference

12 December 2020

The antioxidant supplement myth

1 reference

12 December 2020

Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients

1 reference

12 December 2020

Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria.

1 reference

12 December 2020

Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed diet

1 reference

12 December 2020

Plasma zinc, copper, and erythrocyte superoxide dismutase in children with phenylketonuria

1 reference

12 December 2020

Influence of dietary methionine on the metabolism of selenomethionine in rats

1 reference

12 December 2020

Evidence that l-Carnitine and Selenium Supplementation Reduces Oxidative Stress in Phenylketonuric Patients

1 reference

12 December 2020

The coenzyme Q10 content of the average Danish diet.

1 reference

12 December 2020

Coenzyme Q10 in the diet--daily intake and relative bioavailability

1 reference

12 December 2020

Inhibition of chick brain cholesterogenic enzymes by phenyl and phenolic derivatives of phenylalanine

1 reference

12 December 2020

Serum carnitine level in phenylketonuric children under dietary control in Greece

1 reference

12 December 2020

Selenium supplementation: plasma glutathione peroxidase an indicator of selenium intake

1 reference

12 December 2020

Poor zinc and selenium status in phenylketonuric children and adolescents in Brazil

1 reference

12 December 2020

Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development

1 reference

12 December 2020

Nutrition in phenylketonuria

1 reference

12 December 2020

Plasma amino acid response to ingestion of L-amino acids and whole protein

1 reference

12 December 2020